Covered recipient · General Payments record
ABBY N PICARD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,952.21
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.24 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $79.14 | 3 |
| PFIZER INC. | $57.89 | 2 |
| GENZYME CORPORATION | $49.08 | 1 |
| Dermavant Sciences, Inc. | $43.50 | 2 |
| Sandoz Inc. | $42.20 | 2 |
| Amgen Inc. | $38.98 | 1 |
| Lilly USA, LLC | $32.97 | 1 |
| LEO Pharma Inc. | $30.00 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.71 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.41 | 1 |
| Arcutis Biotherapeutics, Inc. | $22.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.71 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848989 | CMS |
| ABBVIE INC. | $29.96 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848991 | CMS |
| ABBVIE INC. | $15.47 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848993 | CMS |
| Amgen Inc. | $38.98 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655804 | CMS |
| Arcutis Biotherapeutics, Inc. | $22.36 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121079325 | CMS |
| Dermavant Sciences, Inc. | $18.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128005143 | CMS |
| Dermavant Sciences, Inc. | $24.77 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128005145 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.41 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101442971 | CMS |
| GENZYME CORPORATION | $49.08 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139902378 | CMS |
| LEO Pharma Inc. | $30.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152683739 | CMS |
| Lilly USA, LLC | $32.97 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135457295 | CMS |
| PFIZER INC. | $27.25 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131142076 | CMS |
| PFIZER INC. | $30.64 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131090796 | CMS |
| Sandoz Inc. | $25.41 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089371112 | CMS |
| Sandoz Inc. | $16.79 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089371124 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.71 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152213585 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.